Request an Appointment

Kidney Transplant Program

Eligibility

People with chronic kidney disease who meet certain criteria of kidney function and those on dialysis are most appropriately treated with a kidney transplant. Chronic kidney disease may be caused by many medical conditions, including:

Your transplant team will evaluate you to determine whether a kidney transplant may be safe and beneficial for you. Your comprehensive evaluation will include blood tests, imaging scans and other tests. Doctors will check you for other serious conditions, including chronic infections, cancer, and heart and blood vessel (cardiovascular) disease.

Most people who are evaluated are determined to be eligible for a kidney transplant. Your doctors and transplant team will work with you to promote wellness, lower your risks and improve your outcome after kidney transplant. A care team member will talk with you about the importance of taking your immunosuppressant (anti-rejection) medications to keep your body from rejecting your kidney.

Request an Appointment at Mayo Clinic
Volumes and outcomesResources for physicians
Sept. 11, 2018
Print
References
  1. Scientific Registry of Transplant Recipients. http://www.srtr.org/default.aspx. Accessed April 7, 2016.
  2. U.S. News & World Report. U.S. News Best Hospitals 2015-16. http://health.usnews.com/best-hospitals/rankings. Accessed Feb. 22, 2016.
  3. Orandi BJ, et al. Kidney transplants from incompatible live donors. New England Journal of Medicine. 2016;374:940.
  4. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 5, 2016.
  5. Schinstock CA (expert opinion). Mayo Clinic, Rochester, Minn. April 18, 2014.
  6. Lallas CD, et al. The development of a laparoscopic donor nephrectomy program in a de novo renal transplant program: Evolution of technique and results in over 200 cases. Journal of the Society of Laparoendoscopic Surgeons. 2006;10:135.
  7. Mai ML (expert opinion). Mayo Clinic, Jacksonville, Fla. April 26, 2016.
  8. Stulak JM, et al. Combined heart and abdominal organ transplantation: Excellent outcomes gained from a unique experience. Journal of Heart and Lung Transplantation. 2014;33:S278.
  9. Li H, et al. Assessing the efficacy of kidney paired donation — Performance of an integrated three-site program. Transplantation. 2014;98:300.
  10. Cornell LD, et al. Positive crossmatch kidney transplant recipients treated with eculizumab: Outcomes beyond 1 year. American Journal of Transplantation. 2015;15:1293.
  11. Shapiro R, et al. Benefits and complications of laparoscopic donor nephrectomy. http://www.uptodate.com/home. Accessed March 11, 2016.
  12. Polycystic kidney disease. National Institutes of Diabetes and Digestive Kidney Diseases. http://kidney.niddk.nih.gov/kudiseases/pubs/polycystic/. Accessed March 16, 2016.
  13. Raichlin E, et al. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplantation Proceedings. 2011;43:1871.
  14. Heilman RL, et al. Steroid avoidance immunosuppression in low-risk kidney transplant recipients. Transplantation Proceedings. 2005;37:1785.
  15. Jay CL, et al. Reassessing preemptive kidney transplantation in the United States: Are we making progress? Transplantation. 20165;100:1120. http://www.transplantjournal.com. Accessed April 6, 2016.
  16. Bentall A, et al. Five-year outcomes in living donor kidney transplants with a positive crossmatch. American Journal of Transplantation. 2013;13:76.
  17. Prieto M (expert opinion). Mayo Clinic, Rochester, Minn. May 11, 2016.
  18. Dharnidharka VR, et al. Kidney transplantation in children. New England Journal of Medicine. 2014;371:549.
  19. Barbara Woodward Lips Patient Education Center. Your child's kidney transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  20. Kidney transplant team describes current work. Mayovox. 1967;18:24.
  21. Kudva YC (expert opinion). Mayo Clinic, Rochester, Minn. March 14, 2016.
  22. Barbara Woodward Lips Patient Education Center. Kidney transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  23. Rossi AP, et al. Evaluation of the potential renal transplant recipient. http://www.uptodate.com/home. Accessed April 6, 2016.
  24. Cramer CH II (expert opinion). Mayo Clinic, Rochester, Minn. April 27, 2016.
  25. Li H, et al. The limits of paired donation — Who doesn't get transplanted? American Journal of Transplantation. 2013;13(suppl 5). http://www.atcmeetingsabstracts.com/abstract/limits-of-paired-donation-who-doesn’t-get-transplanted-the/. Accessed April 27, 2016.
  26. Crespo HS, et al. Kidney transplantation in the septuagenarian. American Journal of Transplantation. 2015;15(suppl 3). http://www.atcmeetingabstracts.com/abstract/kidney-transplantation-in-the-septuagenarian/. Accessed April 27, 2016.
  27. Taner T, et al. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney International. 2016:89:909.

Mayo Clinic in Rochester, Minn., has been recognized as the best Nephrology hospital in the nation for 2018-2019 by U.S. News & World Report.

Learn more about this top honor

Kidney Transplant Program

Sections